Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500099569Phase 4Not yet recruiting
Phase 4 trial of dexmedetomidine in sleep disorder (3 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of sleep disorder on the night of operation. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500099569.